BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1201167)

  • 1. Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1975 Aug; 47(8):885-8. PubMed ID: 1201167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of suxamethonium blockade by neostigmine in patients with atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1975 Mar; 47(3):416-8. PubMed ID: 1138751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
    Scaf AH; van den Akker J; Westenberg HG
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189
    [No Abstract]   [Full Text] [Related]  

  • 4. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexafluorenium bromide: current status and a review.
    Britton RM; Figueroa M
    Anesth Analg; 1973; 52(1):100-5. PubMed ID: 4567515
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of suxamethonium-induced changes in serum potassium concentration by hexafluorenium. Is their combined use justified?
    Radnay PA; Badola RP; Dalsania A; El-Gaweet EI; Duncalf D
    Br J Anaesth; 1979 May; 51(5):447-51. PubMed ID: 444345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of the enzymic hydrolysis of suxamethonium in plasma and tissues: studies in cats.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1971 Oct; 43(2):341-8. PubMed ID: 4333803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.
    Scaf AH; van den Akker J; Berends F
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between the level of cholinesterase in plasma and the action of suxamethonium in animals.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1970 Dec; 40(4):775-89. PubMed ID: 4322043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.
    Baraka A
    Anaesthesia; 1992 Mar; 47(3):217-9. PubMed ID: 1314525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of tacrine on neuromuscular transmission: a comparison with hexafluorenium.
    Karis JH; Nastuk WL; Katz RL
    Br J Anaesth; 1966 Oct; 38(10):762-74. PubMed ID: 5954069
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of cholinesterase in the myoneural synapses by decamethonium and ditilin].
    Danilov AF
    Farmakol Toksikol; 1967; 30(6):664-9. PubMed ID: 5598433
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of the neuromuscular effect of succinylcholine by hexafluorenium.
    FOLDES FF; HILLMER NR; MOLLOY RE; MONTE AP
    Anesthesiology; 1960; 21():50-8. PubMed ID: 13823695
    [No Abstract]   [Full Text] [Related]  

  • 15. The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics.
    Vermeer GA; Hess SW
    Anaesthesist; 1974 Feb; 23(2):72-8. PubMed ID: 4458482
    [No Abstract]   [Full Text] [Related]  

  • 16. Responses to small doses of suxamethonium in four children with abnormal cholinesterase--a case report.
    Brown TC; Meretoja OA; Bell B; Clare D
    Anaesth Intensive Care; 1990 Nov; 18(4):477-8. PubMed ID: 2268012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromuscular effects of hexafluorene bromide in association with succinylcholine].
    Rodríguez Alvarez E
    Rev Esp Anestesiol Reanim; 1978 Sep; 25(5):426-44. PubMed ID: 155278
    [No Abstract]   [Full Text] [Related]  

  • 18. Presence of suxamethonium fasciculations in patients with atypical plasma cholinesterase.
    Mogensen JV
    Br J Anaesth; 1976 Oct; 48(10):1030. PubMed ID: 990144
    [No Abstract]   [Full Text] [Related]  

  • 19. Relative importance of the enzymic hydrolysis of sexamethonium in plasma and tissues: studies in Rhesus monkeys.
    Peck AW
    Br J Pharmacol; 1972 May; 45(1):64-70. PubMed ID: 4625272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.